Active Research
-
A Phase 3, Open-label Study Evaluating the Long term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Primary Investigator: Pancham MD, Krishna
IRB ID: 2022-056 (OPEN)
-
Participation in the Cystic Fibrosis Patient Registry
Primary Investigator: Schultz MD, Karen D
IRB ID: 394 (OPEN)
-
STOP360-IP-22: Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)
Primary Investigator: Schultz MD, Karen D
IRB ID: 2022-091 (OPEN)
-
TDN_REACH-OB-23: A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators
Primary Investigator: Schultz MD, Karen D
IRB ID: 2024-070 (OPEN)
-
unknown
Primary Investigator: Pancham MD, Krishna
IRB ID: 2025-011 (OPEN)